Electroporation ablation console with real-time treatment
This system uses high-frequency electrical signals to monitor tissue ablation in real time during electroporation procedures, which destroy unwanted tissue using rapid electrical pulses. Before and during treatment, the system measures how the tissue resists electrical current — a property called impedance — at frequencies above 1 MHz. As the electroporation pulses do their work and cells are disrupted, the impedance changes in predictable ways, allowing the system to track progress automatically. This means a clinician can see exactly how much tissue has been treated and know when to stop, rather than relying on time estimates or post-procedure imaging.
What you could build
A smart electroporation ablation console or add-on module for interventional oncology and cardiac electrophysiology that displays a live treatment-progress dashboard, reducing retreatment rates and over-treatment risk; target buyers are hospital systems, catheter-lab equipment OEMs, and ablation device manufacturers.
Who in Virginia should care
Virginia-based hospital systems with interventional oncology or electrophysiology programs, and defense-adjacent biomedical device contractors around Northern Virginia and the Hampton Roads corridor, would be natural commercialization or licensing partners.
Readiness: Prototype likely
Concept — described but not yet demonstrated. Lab validated — supported by experimental results in the patent. Prototype likely — the text describes a built, working embodiment.
Readiness is inferred from the patent text, not from a lab visit.
The record
- Inventors
- Robert Neal II, Rafael V. Davalos
- Granted
- March 26, 2019
- Status
- Granted patent
- Patent number
- 10238447
Ready to talk?
Virginia Tech Intellectual Properties handles licensing for this technology.
Prosim summaries are generated from public patent text and are not legal advice.